DXCM vs IVF · P/E 63, rev $2.50B vs rev $2.2M
DexCom Inc (DXCM) versus INVO Fertility, Inc. (IVF) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
INVO Fertility, Inc. (IVF) is a medical devices company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported IVF revenue for 2026-06-30 was $2.2M. Net income was $888.7K. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. IVF currently screens at market cap $2.8M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. IVF currently screens at market cap $2.8M.
Not investment advice. Open the DXCM and IVF stock pages for the full models.
Not investment advice.